Cargando…
GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer
BACKGROUND: Prostate cancer is currently the second most lethal malignancy in men worldwide due to metastasis and invasion in advanced stages. Studies have revealed that androgen deprivation therapy can induce stable remission in patients with advanced prostate cancer, although most patients will de...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617133/ https://www.ncbi.nlm.nih.gov/pubmed/37904122 http://dx.doi.org/10.1186/s12935-023-03093-4 |